Point-of-Care Marketing in Pharma: Channels, Buying, and Measurement
How point-of-care marketing works for pharma: EHR messaging, waiting and exam room media, clinical apps, buying, pricing, rules, and measurement.
The short answer
Point-of-care marketing reaches HCPs and patients where care happens: inside EHR and e-prescribing workflows, in drug reference and clinical apps, and on screens and print in waiting and exam rooms. It puts approved messages close to the moment a therapy is chosen. It is bought mostly through specialist vendors on guaranteed reach or sponsorships, and is best measured with Rx outcome studies that compare exposed and similar unexposed HCPs or practices.
Most HCP media reaches clinicians when they are reading the news or scrolling between patients. Point-of-care media tries to reach them at the moment a treatment decision is made, and to reach patients while they wait to see the doctor. That timing is the appeal. It also brings stricter rules and harder measurement.
The main point-of-care channels
| Channel | Audience | Example formats |
|---|---|---|
| EHR and e-prescribing | HCPs in workflow | Sponsored messages, coverage notices, support program alerts |
| Drug reference and clinical apps | HCPs | Display, sponsored content, alerts |
| Exam room screens | Patients and HCPs | Interactive tablets, wallboards |
| Waiting room screens | Patients, caregivers | Video loops, condition education |
| Print in offices | Patients | Brochures, posters |
| Pharmacy | Patients | Counseling materials, screens |
The EHR advertising and clinical app articles go deeper on the HCP side. Waiting-room media covers the patient side.
Why brands use it
- Timing. Messages arrive near prescribing or treatment discussion.
- Reach to low-access HCPs. Useful when reps cannot get in. See physician access strategy.
- Patient activation. Waiting and exam room content can prompt questions during the visit.
- Context. A clinical setting adds weight to education messages.
Rules to know
Point-of-care messages are promotion and go through the same review as other materials. Extra considerations:
- EHR messages must not interfere with clinical decision support or appear to be clinical guidance.
- Vendors and EHR platforms set their own content rules.
- Patient-facing screens in offices reach a mixed audience, so content usually follows consumer standards.
- Any use of patient data for reporting must follow HIPAA and privacy rules. See HIPAA-safe reporting.
How it is bought
Most point-of-care is bought directly from specialist vendors. Common models:
- Guaranteed HCP reach against a target list.
- Sponsorships of a placement or condition category.
- Screen networks priced by locations or estimated impressions.
The pricing guide explains these models and how to compare them.
Measurement
Point-of-care measurement has three levels:
- Delivery. Messages served, screens live, HCPs reached on the target list.
- Engagement. Clicks, interactions, time with content.
- Outcomes. Prescriptions among exposed HCPs or practices versus matched controls.
Engagement can be misleading: HCPs rarely click in a workflow, and that does not mean the message failed. The point-of-care measurement article covers pixels and Rx lift, and point-of-care KPIs explains which numbers to report.
Fitting it into the plan
Point-of-care works best as part of a coordinated plan:
- Programmatic and endemic for reach and awareness.
- Point of care for the moment of decision.
- Field and email for depth.
The integration article shows how to plan and measure them together.
Common mistakes
- Judging point-of-care on click rates.
- Buying screen networks without checking how many target practices they reach.
- Separate measurement studies for each channel that each claim the same prescriptions.
- Message content written for display ads dropped into EHR formats.
Practical takeaway
Before buying point-of-care, ask each vendor to match your target NPI list and report how many target HCPs or practices they can reach. Then agree an outcome study design with a control group before launch, not after.
Frequently asked questions
What is point-of-care marketing?
Marketing delivered in healthcare settings or clinical workflows, such as EHR messages, clinical apps, and waiting or exam room screens, so messages appear near the moment of care.
Is point-of-care media programmatic?
Mostly not. Much of it is sold directly by specialist vendors, though some digital point-of-care inventory is available through programmatic deals.
How is point-of-care measured?
Through Rx outcome studies that match exposed HCPs or practices to prescription data and compare them with similar unexposed ones. Engagement metrics alone are weak evidence.
Sources
- FDA, Office of Prescription Drug Promotion (OPDP)
- HHS, Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates
- HHS, Guidance Regarding Methods for De-identification of PHI
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.